Page last updated: 2024-09-03

ezogabine and Epilepsy, Complex Partial

ezogabine has been researched along with Epilepsy, Complex Partial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burke, RA; Faulkner, MA	1

Reviews

1 review(s) available for ezogabine and Epilepsy, Complex Partial

Article	Year
Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel. Expert opinion on drug safety, 2013, Volume: 12, Issue:6 Topics: Anticonvulsants; Carbamates; Drug Monitoring; Drug Resistance; Epilepsy, Complex Partial; Humans; Nitriles; Patient Selection; Phenylenediamines; Potassium Channels, Voltage-Gated; Pyridones; Receptors, AMPA	2013

Article

Year

Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel.

Expert opinion on drug safety, 2013, Volume: 12, Issue:6

Topics: Anticonvulsants; Carbamates; Drug Monitoring; Drug Resistance; Epilepsy, Complex Partial; Humans; Nitriles; Patient Selection; Phenylenediamines; Potassium Channels, Voltage-Gated; Pyridones; Receptors, AMPA

2013